Finance

Lists
Why is ALLR down 3.31%?
Dive Deeper
ALLR:NASDAQ
Allarity Therapeutics Inc
$1.17
-3.31%
(-0.040) 1D
$1.20
+2.38% (+0.028)
After hours
Closed: Sep 21, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALLR...
Open
$1.20
High
$1.20
Low
$1.13
Mkt. cap
18.62M
Avg. vol.
97.38K
Volume
0.00
52-wk high
$1.84
52-wk low
$0.77
EPS
-$0.79
Beta
0.27
Shares outstanding
15.91M
No. of employees
7
Open
$1.20
High
$1.20
Low
$1.13
Mkt. cap
18.62M
Avg. vol.
97.38K
Volume
0.00
52-wk high
$1.84
52-wk low
$0.77
EPS
-$0.79
Beta
0.27
Shares outstanding
15.91M
No. of employees
7
News stories
From web sources and news partners
About Allarity Therapeutics Inc
CEO-
Employees7
Founded-
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteallarity.com
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
$10.25
+776.1%
06/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
320.00K
25.00K
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.20M
2.51M
1.30M
1.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.32M
1.56M
1.42M
1.33M
Operating expense
2.52M
3.24M
2.71M
2.67M
Total operating expenses
2.52M
3.24M
2.71M
2.67M
Operating income
-2.52M
-2.92M
-2.69M
-2.67M
Other non operating income
-
-
-
-128.00K
EBT including unusual items
-2.81M
-3.37M
-2.75M
-3.40M
EBT excluding unusual items
-2.81M
-3.37M
-2.75M
-3.40M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-833.00K
-
-
Net income
-2.81M
-3.37M
-2.75M
-3.40M
Net profit margin
-
-1,054.06%
-11,000.00%
-
Earnings per share
-0.19
-0.21
-0.17
-0.21
Interest and investment income
187.00K
155.00K
163.00K
217.00K
Interest expense
-57.00K
-59.00K
-229.00K
-719.00K
Net interest expenses
130.00K
96.00K
-66.00K
-502.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.51M
-2.91M
-
-2.64M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps